KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Boston Scientific (BSX) over the last 6 years, with Q4 2025 value amounting to $365.0 million.

  • Boston Scientific's Depreciation & Amortization (CF) rose 488.51% to $365.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.4 billion, marking a year-over-year increase of 780.14%. This contributed to the annual value of $1.4 billion for FY2025, which is 780.14% up from last year.
  • Boston Scientific's Depreciation & Amortization (CF) amounted to $365.0 million in Q4 2025, which was up 488.51% from $342.0 million recorded in Q3 2025.
  • Boston Scientific's 5-year Depreciation & Amortization (CF) high stood at $365.0 million for Q4 2025, and its period low was $263.0 million during Q2 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $299.0 million (2023), whereas its average is $303.1 million.
  • Per our database at Business Quant, Boston Scientific's Depreciation & Amortization (CF) crashed by 436.36% in 2021 and then soared by 1176.47% in 2025.
  • Over the past 5 years, Boston Scientific's Depreciation & Amortization (CF) (Quarter) stood at $290.0 million in 2021, then increased by 1.38% to $294.0 million in 2022, then rose by 6.46% to $313.0 million in 2023, then increased by 11.18% to $348.0 million in 2024, then increased by 4.89% to $365.0 million in 2025.
  • Its last three reported values are $365.0 million in Q4 2025, $342.0 million for Q3 2025, and $336.0 million during Q2 2025.